Randomised controlled trial
Pryor et al. — pivotal dapoxetine trials
Pryor JL et al., The Lancet, 2006;368(9539):929–937
- Participants
- 2,614
- Duration
- 12 weeks (pooled phase III)
- Comparator
- Placebo
In men with premature ejaculation, dapoxetine 30 mg and 60 mg produced significantly greater increases in intravaginal ejaculatory latency time (IELT) versus placebo, with concomitant improvement in patient-reported outcomes. Trial results do not predict individual outcomes.
Read the full paper
